Accession Number: | 0001209191-20-064378 |
Date: | 2020-12-15 |
Issuer: | AMNEAL PHARMACEUTICALS, INC. (AMRX) |
Original Submission Date: |
GEORGE JEFFREY P.
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER, NJ 08807
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
CLASS A COMMON STOCK | 2020-12-15 | M | 7,522 | a | $0.00 | 31,332 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-12-15 | deemed execution date | M | 7,522 (d) | class a common stock 7,522 | $0.00 | 0 | direct |
ID | footnote |
---|---|
f1 | each restricted stock units represents a contingent right to receive on share of the issuer's class a common stock. |
f2 | on december 14, 2019, the reporting person was granted 7,522 restricted stock units vesting on december 15, 2020. |